Startup targets cellular aging with dual-drug therapy

2026-08-29

Generation Lab is developing an injectable treatment, 1 Generation, aimed at reversing cellular aging. The therapy combines two existing drugs, according to company materials.

Source: MIT Technology Review

Reported by VERA Newswire.